Share on LinkedInShare on LinkedIn

ARTICLE · 15 OCTOBER 2010

Repercussions Expected On Medicine Advertising Campaign In Mexico

Olivares
Olivares
Contributor
Olivares

Olivares

Our mission is to provide innovative solutions and highly specialized legal advice for clients...

View firm profile
Explore more from Olivares

A recent high-profile marketing initiative by a Mexican pharmaceutical company appears to be a clear example of unfair competition.

MexicoIntellectual Property

A recent high-profile marketing initiative by a Mexican pharmaceutical company appears to be a clear example of unfair competition. This article puts the campaign in context and looks at the likely outcome for the advertiser

A bold new television advertising and publicity campaign was launched recently by a pharmaceutical company called Genoma Lab.

The campaign was designed to raw attention to the company's newest product – a line of generic pharmaceuticals called Primer Nivel ('First Level'). This name has a particular meaning within the Mexican health system. It is not a registered trademark even though it appears to be used as such in the promotions.

Many pharmaceutical companies, both local and international, have good reason to be disturbed by this development due to the powerful nature of the advertising campaign, which appears to include false or misleading information. For instance, it seems to suggest that Primer Nivel is the product maker's brand name.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from